Clinical Trials
12 trialsNCT04973683 2026-04-23
AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT05377996 2026-04-14
A Study of XMT-1660 in Participants With Solid Tumors
Mersana Therapeutics
Phase 1 Recruiting
NCT01046487 2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1 Completed
NCT05194072 2026-01-09
A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors
Seagen Inc.
Phase 1 Terminated
NCT06462183 2025-11-14
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
Rgenta Therapeutics Inc
Phase 1 Recruiting
NCT06805825 2025-09-23
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Novelty Nobility, Inc.
Phase 1 Recruiting
NCT02783300 2025-03-10
Meteor 1
GlaxoSmithKline
Phase 1 Completed
NCT04249947 2025-02-17
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)
Poseida Therapeutics, Inc.
Phase 1 Terminated
NCT03886831 2023-03-28
A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies
Prelude Therapeutics
Phase 1 Completed
NCT03287427 2023-02-15
MYPHISMO
Peter MacCallum Cancer Centre, Australia
Phase 1 Completed
NCT03291002 2021-11-04
Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC
CureVac
Phase 1 Unknown
NCT03680560 2020-03-31
Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers
Cogent Biosciences, Inc.
Phase 1 Terminated